Letrozole
Showing 26 - 50 of 774
ive Alzheimer's Medicines- Anastrozole vs Exemestane/Letrozole
Active, not recruiting
- Breast Cancer
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 1, 2022
Breast Cancer Trial (dalpiciclib plus letrozole)
Not yet recruiting
- Breast Cancer
- dalpiciclib plus letrozole
- (no location specified)
Aug 21, 2022
Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)
Active, not recruiting
- Breast Cancer
- Letrozole
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 13, 2022
Breast Cancer Trial in Groningen (Palbociclib, FES PET, Letrozole)
Completed
- Breast Cancer
- Palbociclib
- +2 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Oct 11, 2022
Endometrial Cancer Trial (Letrozole 2.5mg)
Not yet recruiting
- Endometrial Cancer
- Letrozole 2.5mg
- (no location specified)
Jul 26, 2022
Advanced Breast Cancer Trial (Dalpiciclib+ letrozole +capecitabine)
Not yet recruiting
- Advanced Breast Cancer
- Dalpiciclib+ letrozole +capecitabine
- (no location specified)
Jul 21, 2022
Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,
Recruiting
- Breast Adenocarcinoma
- +2 more
- Biospecimen Collection
- Letrozole
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin
Recruiting
- Carcinoma, Ovarian Epithelial
- Low Grade Serous Adenocarcinoma of Ovary
- Letrozole tablets
- carboplatin AUC 5 and paclitaxel 175 mg/m2
-
Brescia, BS, Italy
- +1 more
Oct 26, 2022
Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)
Not yet recruiting
- Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
- Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
-
Singapore, SingaporeNational Cancer Centre Singapore
Oct 13, 2022
Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)
Terminated
- Estrogen Receptor Positive
- +16 more
- Biopsy of Breast
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022
Estrogen Receptor-positive Breast Cancer Trial in Nashville (2-Week Ketogenic Diet, Letrozole)
Recruiting
- Estrogen Receptor-positive Breast Cancer
- 2-Week Ketogenic Diet
- Letrozole
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Sep 20, 2022
Endometriotic Cyst of Ovary Trial (Letrozole, Placebo)
Not yet recruiting
- Endometriotic Cyst of Ovary
- Letrozole
- Placebo
- (no location specified)
Aug 2, 2022
Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)
Not yet recruiting
- Breast Cancer
- Pyrotinib
- +7 more
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Dec 2, 2022
Breast Cancer Trial in Shenyang (Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole)
Recruiting
- Breast Cancer
- Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Sep 12, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +5 more
- Letrozole
- Simvastatin
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jul 14, 2022
Miscarriage Trial in Kolkata (Mifepristone, Letrozole)
Recruiting
- Miscarriage
- Mifepristone
- Letrozole
-
Kolkata, West Bengal, IndiaCalcutta National Medical College and Hospital
Jul 24, 2022
Endometrial Tumors, Atypical Endometrial Hyperplasia, Progesterone Resistance Trial in Shanghai (GnRHa, Letrozole 2.5mg,
Recruiting
- Endometrial Neoplasms
- +2 more
- GnRHa
- +3 more
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Jul 29, 2022
Pregnancy Trial in Salt Lake City (30 mg letrozole followed by 800 mcg misoprostol)
Completed
- Pregnancy
- 30 mg letrozole followed by 800 mcg misoprostol
-
Salt Lake City, UtahPlanned Parenthood Salt Lake Health Center
Jun 14, 2022
Advanced Breast Cancer, Female Breast Cancer Trial in Beijing (FCN-437c, Letrozole or anastrozole, Goserelin acetate, Placebo,
Recruiting
- Advanced Breast Cancer
- Female Breast Cancer
- FCN-437c, Letrozole or anastrozole, Goserelin acetate
- Placebo, Letrozole or anastrozole, Goserelin acetate
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Jul 4, 2022
Infertility Trial in Assiut (Letrozole, ovarian drilling)
Recruiting
- Infertility
- Letrozole
- ovarian drilling
-
Assiut, EgyptAssiut University
May 6, 2022
Subfertility Trial in Hong Kong, Beijing (Letrozole)
Recruiting
- Subfertility
- Letrozole
-
Hong Kong, Hong Kong, China
- +1 more
Mar 15, 2022
Infertility Trial in San Francisco (Tamoxifen, Letrozole)
Recruiting
- Infertility
- Tamoxifen
- Letrozole
-
San Francisco, CaliforniaUniversity of California at San Francisco
Apr 29, 2022
Advanced Breast Cancer Trial in Harbin (XZP-3287+ Letrozole/Anastrozole, Placebo + Letrozole/Anastrozole)
Not yet recruiting
- Advanced Breast Cancer
- XZP-3287+ Letrozole/Anastrozole
- Placebo + Letrozole/Anastrozole
-
Harbin, Heilongjiang, ChinaHarbin Medical University Cancer Hospital
Feb 16, 2022
Hepatopulmonary Syndrome Trial in San Francisco, Rochester (Letrozole, Placebo)
Recruiting
- Hepatopulmonary Syndrome
- Letrozole
- Placebo
-
San Francisco, California
- +1 more
Mar 23, 2022